Effects Of Finerenone - A Novel Non-steroidal Mineralocorticoid Receptor Antagonist In A Model Of Pressure Overload-induced Cardiac Hypertrophy

被引：0
|
作者：
Grune, Jana
Benz, Verena
Brix, Sarah
Ban, Zsofia
Salatzki, Janek
Hoeft, Beata
Foryst-Ludwig, Anna
Klopfleisch, Robert
Kolkhof, Peter
Kintscher, Ulrich
机构：
来源：
HYPERTENSION | 2014年 / 64卷
关键词：
hypertrophy; cardioprotective drugs;
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
007
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [31] Sarcoplasmic reticulum function in pressure overload-induced cardiac hypertrophy
    Yao, XH
    Cantor, E
    Vasanji, Z
    Greville, J
    Netticadan, T
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2004, 36 (04) : 636 - 636
  • [32] Ryanodine Receptor Type 2 Is Required for the Development of Pressure Overload-Induced Cardiac Hypertrophy
    Zou, Yunzeng
    Liang, Yanyan
    Gong, Hui
    Zhou, Ning
    Ma, Hong
    Guan, Aili
    Sun, Aijun
    Wang, Ping
    Niu, Yuhong
    Jiang, Hong
    Takano, Hiroyuki
    Toko, Haruhiro
    Yao, Atsushi
    Takeshima, Hiroshi
    Akazawa, Hiroshi
    Shiojima, Ichiro
    Wang, Yuqi
    Komuro, Issei
    Ge, Junbo
    HYPERTENSION, 2011, 58 (06) : 1099 - U363
  • [33] Shensongyangxin protects against pressure overload-induced cardiac hypertrophy
    Shen, Di-Fei
    Wu, Qing-Qing
    Ni, Jian
    Deng, Wei
    Wei, Cong
    Jia, Zhen-Hua
    Zhou, Heng
    Zhou, Meng-Qiao
    Bian, Zhou-Yan
    Tang, Qi-Zhu
    MOLECULAR MEDICINE REPORTS, 2016, 13 (01) : 980 - 988
  • [34] Pronounced cardiac protection by BAY 94-8862, a novel non-steroidal mineralocorticoid receptor antagonist in a preclinical rat model of heart failure
    Albrecht-Kuepper, B.
    Kretschmer, A.
    Kast, R.
    Baerfacker, L.
    Schaefer, S.
    Kolkhof, P.
    EUROPEAN HEART JOURNAL, 2012, 33 : 7 - 7
  • [35] Novel non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease
    Kintscher, Ulrich
    Bakris, George L.
    Kolkhof, Peter
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (13) : 3220 - 3234
  • [36] Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
    Xu, Si-Chi
    Ma, Zhen-Guo
    Wei, Wen-Ying
    Yuan, Yu-Pei
    Tang, Qi-Zhu
    PPAR RESEARCH, 2017, 2017
  • [37] Diacylglycerol kinase ζ attenuates pressure overload-induced cardiac hypertrophy
    Harada, Mutsuo
    Takeishi, Yasuchika
    Arimoto, Takanori
    Niizeki, Takeshi
    Kitahara, Tatsuro
    Goto, Kaoru
    Walsh, Richard A.
    Kubota, Isao
    CIRCULATION JOURNAL, 2007, 71 (02) : 276 - 282
  • [38] Characterization of a novel non-steroidal glucocorticoid receptor antagonist
    Li, Qun-Yi
    Zhang, Meng
    Hallis, Tina M.
    DeRosier, Therese A.
    Yue, Jian-Min
    Ye, Yang
    Mais, Dale E.
    Wang, Ming-Wei
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 391 (03) : 1531 - 1536
  • [39] Finerenone, a novel selective non-steroidal mineralocorticoid receptor antagonist with a balanced cardiorenal tissue distribution confers pronounced end organ protection at low natriuretic doses
    Kolkhof, P.
    Delbeck, M.
    Kretschmer, A.
    Steinke, W.
    Hartmann, E.
    Baerfacker, L.
    Eitner, F.
    Albrecht-Kuepper, B.
    Schaefer, S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 210 - 210
  • [40] Activation of transient receptor potential vanilloid 4 is involved in pressure overload-induced cardiac hypertrophy
    Zou, Yan
    Zhang, Miaomiao
    Wu, Qiongfeng
    Zhao, Ning
    Chen, Minwei
    Yang, Cui
    Du, Yimei
    Han, Bing
    ELIFE, 2022, 11
12345